(Q34180539)

31 July 2017

1 reference

title

One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010. (English)

1 reference

Peer Carsten Tfelt-Hansen

31 July 2017

1 reference

series ordinal

1

object named as

Peer C Tfelt-Hansen

1 reference

31 July 2017

Peter J Koehler

2

1 reference

31 July 2017

publication date

1 May 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

51

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

752-778

1 reference

Persistent oligemia of rat cerebral cortex in the wake of spreading depression.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

The neurobiology of vascular head pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Brain stem activation in spontaneous human migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

The early use of ergotamine in migraine. Edward Woakes' report of 1868, its theoretical and practical background and its international reception

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

On some physiological actions of ergot

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Ergotamine in the acute treatment of migraine: a review and European consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Etiology and pathophysiology of headache in the early 17th century, as illustrated by the work of Johan van Beverwijck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Spatial summation of mechanically evoked muscle pain and painful aftersensations in normal subjects and fibromyalgia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Origin of pain in migraine: evidence for peripheral sensitisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Brown-Séquard's comment on Du Bois-Reymond's "hemikrania sympathicotonica".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Leao's cortical spreading depression: from experimental "artifact" to physiological principle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Note on a possible correspondence between the scotomas of migraine and spreading depression of Leão

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Physiological studies of cortical spreading depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Cortical spreading depression-new insights and persistent questions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

History of methysergide in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

METHYSERGIDE IN THE PROPHYLAXIS OF MIGRAINE

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Methysergide in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Fibrotic Disorders Associated with Methysergide Therapy for Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Hemodynamic studies within the brain during migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Changes in regional cerebral blood flow during the course of classic migraine attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Regulation of regional cerebral blood flow during and between migraine attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Timing and topography of cerebral blood flow, aura, and headache during migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Mechanisms of migraine aura revealed by functional MRI in human visual cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Functional MRI-BOLD of visually triggered headache in patients with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

An experimental model of migraine with aura: cortical hypoperfusion following spreading depression in the awake and freely moving rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Long-lasting reduction of cortical blood flow of the brain after spreading depression with preserved autoregulation and impaired CO2 response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

The blood-brain barrier in migraine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Suppression of cortical spreading depression in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Spreading and synchronous depressions of cortical activity in acutely injured human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Association of seizures with cortical spreading depression and peri-infarct depolarisations in the acutely injured human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Substance P and the sensory innervation of intracranial and extracranial feline cephalic arteries. Implications for vascular pain mechanisms in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Delayed inflammation in rat meninges: implications for migraine pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

The discovery and development of the triptans, a major therapeutic breakthrough

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

New appendix criteria open for a broader concept of chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

21 January 2018

Serotonin and migraine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Sumatriptan in acute migraine: pharmacology and review of world experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Effects of methysergide and 5-hydroxytryptamine on carotid blood flow distribution in pigs: further evidence for the presence of atypical 5-HT receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Coronary vasoconstrictor potential of triptans: a review of in vitro pharmacologic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Sumatriptan-naproxen for acute treatment of migraine: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Calcitonin gene-related peptide: functional role in cerebrovascular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

No increase of calcitonin gene-related peptide in jugular blood during migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

CGRP may play a causative role in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Randomized, controlled trial of telcagepant for the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Increased familial risk and evidence of genetic factor in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

A gene for familial hemiplegic migraine maps to chromosome 19

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Evidence for an X-linked genetic component in familial typical migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Tumor necrosis factor B gene polymorphism contributes to susceptibility to migraine without area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

A high-density association screen of 155 ion transport genes for involvement with common migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Molecular genetics of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Sensitization of meningeal sensory neurons and the origin of headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Cutaneous allodynia in the migraine population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Early clinical experience with subcutaneous naratriptan in the acute treatment of migraine: a dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Maximum effect of triptans in migraine? A comment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Focal hyperemia followed by spreading oligemia and impaired activation of rcbf in classic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

THE COMMON MIGRAINE ATTACK MAY NOT BE INITIATED BY CEREBRAL ISCHAEMIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Understanding the Biologic Basis of Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Spreading depolarizations occur in human ischemic stroke with high incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Latent class and genetic analysis does not support migraine with aura and migraine without aura as separate entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Familial Hemiplegic Migraine Type 1 Shows no Hypersensitivity to Nitric Oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Familial Hemiplegic Migraine Type 2 does not Share Hypersensitivity to Nitric Oxide with Common Types of Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

Cortical spreading depression as a putative migraine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2011.01892.X

10.1111/J.1526-4610.2011.01892.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference